Severe type 2 leprosy reaction with COVID-19 with a favourable outcome despite continued use of corticosteroids and methotrexate and a hypothesis on the possible immunological consequences-Reference-Cited by-同舟云学术

Severe type 2 leprosy reaction with COVID-19 with a favourable outcome despite continued use of corticosteroids and methotrexate and a hypothesis on the possible immunological consequences

Published:2021-02 Issue: Volume:103 Page:549-551
ISSN:1201-9712
Container-title:International Journal of Infectious Diseases
language:en
Short-container-title:International Journal of Infectious Diseases

Author:

Saxena Snigdha^ORCID,Khurana Ananta^ORCID,B Savitha,Sardana Kabir^ORCID,Agarwal Aastha,Muddebihal Aishwarya^ORCID,Raina Alok,Paliwal Purnima

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference17 articles.

1. Methotrexate Restores Regulatory T Cell Function Through Demethylation of the FoxP3 Upstream Enhancer in Patients With Rheumatoid Arthritis;Cribbs;Arthritis Rheumatol (Hoboken, NJ),2015

2. Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report;N Engl J Med,2020

3. Part II. high-dose methotrexate with leucovorin rescue for severe COVID-19: An immune stabilization strategy for SARS-CoV-2 induced ‘PANIC’11Prolific Activation of a Network Immune-Inflammatory Crisis [PANIC]. attack;Frohman;J Neurol Sci,2020

4. Risk of COVID-19 in Dermatologic Patients on Long-term Immunomodulatory Therapy;Holcomb;J Am Acad Dermatol,2020

5. Immunosuppressive agents for dermatological indications in the ongoing COVID-19 pandemic: Rationalizing use and clinical applicability;Khurana;Dermatol Ther,2020

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Leprosy and Autoimmunity;Infection and Autoimmunity;2024

2. Time to revisit the purported link of leprosy reactions with infective triggers: An unnecessary economic burden for patients;Tropical Doctor;2023-11-03

3. Leprosy Neuritis due to COVID-19;Infectious Diseases in Clinical Practice;2023-08-21

4. Leprosy reactions after SARS‐COV2 (COVID‐19) infection;Journal of the European Academy of Dermatology and Venereology;2023-04-26

5. Methotrexate as a corticosteroid-sparing agent in leprosy reactions: A French multicenter retrospective study;PLOS Neglected Tropical Diseases;2023-04-20